pharmaphorum
MARCH 19, 2021
DeepVerge has announced trial data showing its COVID-19 Microtox BT breath test can deliver accurate results in under 60 seconds, with a potential roll-out later this year if further tests support it. The company has already completed of the system that resembles a breathalyser in phase 1 and phase 2 studies with the SARS-CoV-2 virus in the safety of laboratories.
Pharma Times
MARCH 15, 2021
Review included available safety data from over 17 million people vaccinated in the EU and UK with COVID-19 jab
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
MARCH 16, 2021
Saamaâs range of Smart applications will be integrated with the Oracle Health Sciences Clinical One platform to help users accelerate drug development.
Drug Patent Watch
MARCH 19, 2021
Annual Drug Patent Expirations for NEOPROFEN Neoprofen is a drug marketed by Recordati Rare and is included in one NDA. It is available from two suppliers. There are three patents…. The post New patent expiration for Recordati Rare drug NEOPROFEN appeared first on DrugPatentWatch - Make Better Decisions.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
MARCH 16, 2021
European regulators questioned the integrity of early batches of Pfizer/BioNTech’s mRNA vaccine, although the matter was resolved before approval, according to information leaked online following a cyberattack. As it conducted its analysis of the vaccine in December, the European Medicines Agency’s systems were targeted by unknown hackers. Following this, more than 40 megabytes of classified information from the agency’s review were published on the dark web and several journalists, including th
Pharma Times
MARCH 16, 2021
Clinical Researcher of the Year – The Americas finalists reveal their positive experiences with the 2020 competition.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Drug Patent Watch
MARCH 19, 2021
Annual Drug Patent Expirations for PROAIR+DIGIHALER Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…. The post New patent for Teva Branded drug PROAIR DIGIHALER appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
MARCH 19, 2021
A host of companies are looking at cough apps to detect the presence of COVID-19. But one company called Hyfe wants to take the idea a step further and use them to detect future pandemics, reports Richard Staines. . The pandemic has seen a plethora of digital tools emerge to help manage patients remotely, with the ubiquitous use of smartphone technology allowing medics to monitor patients’ vital signs without risky face-to-face contact.
Pharma Times
MARCH 17, 2021
Vaccine candidate has previously been granted FDA fast track designation
Drug Channels
MARCH 19, 2021
Today’s guest post comes from Brian Haenni, Vice President of Hub Solutions at ConnectiveRx. Brian discusses the benefits of digital patient support services. To learn more about ConnectiveRx’s patient support capabilities, register for their April 14, 2021 webinar, Transforming the Patient Support Experience. Read on for Brian’s insights. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Patent Watch
MARCH 19, 2021
Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…. The post New patent for Teva Branded drug PROAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
MARCH 19, 2021
This content is password protected. To view it please enter your password below: Password: The post Protected: Using AI to make a big impact for emerging and mid-sized biopharma companies appeared first on.
Pharma Times
MARCH 15, 2021
SleepHub device to be assessed in people with Parkinson's associated sleep issues
Pharma in Brief
MARCH 18, 2021
On March 8, 2021, the Ontario Superior Court granted summary judgment dismissing novel claims by Apotex under the UK and Ontario Statutes of Monopolies , the Trademarks Act , and at common law. It is the first decision on the merits of Apotex’s novel claims and arises in the context of litigation relating to Eli Lilly’s patented olanzapine product (marketed as Zyprexa®).
Drug Patent Watch
MARCH 19, 2021
Annual Drug Patent Expirations for GALAFOLD Galafold is a drug marketed by Amicus Theraps Us and is included in one NDA. There are twenty-one patents protecting this drug. This drug…. The post New patent for Amicus Theraps drug GALAFOLD appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
MARCH 15, 2021
A clinical trial has found that Novavax’ COVID-19 vaccine is 86% protective against the UK variant of SARS-CoV-2, only slightly lower than the 96% efficacy seen with the original strain of the virus. . The phase 3 trial – which takes Novavax’ NVX?CoV2373 shot a step closer to approval – also found that it was 100% effective in preventing severe COVID-19.
Pharma Times
MARCH 19, 2021
MHRA and EMA conclude the vaccine's benefits continue to outweigh risks
Pharma Mirror
MARCH 18, 2021
With the acquisition of the Spanish manufacturer STE Tecpharm, S. L., Romaco strengthens its position as a turnkey supplier of processing technologies. In particular, Tecpharm’s patented drum coaters will complement Romaco Innojet’s granulation and fluid bed technologies. On 18 March 2021, Romaco Holding GmbH announced the purchase of the Spanish manufacturer of processing technology STE Tecpharm, S.
Drug Patent Watch
MARCH 19, 2021
Annual Drug Patent Expirations for ARMONAIR+DIGIHALER Armonair Digihaler is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are twenty-one…. The post New patent for Teva Pharm drug ARMONAIR DIGIHALER appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
MARCH 18, 2021
The demise of the pharmaceutical sales representative has been greatly exaggerated over the years. But in the wake of the COVID-19 pandemic, there is an even greater need to re-examine the rep’s role. How can a field force evolve to deal with current challenges and be future-fit for the way we will be working in the post-pandemic world? The current restrictions on face-to-face meetings have exacerbated the trend of sales reps’ reduced access to healthcare customers.
Pharma Times
MARCH 19, 2021
PCR-based test has a sample collection to result time of 25 minutes
Pharma Marketing Network
MARCH 17, 2021
[link]. Marketing and medical affairs are often perceived as being separate. What happens when drug companies market their own products? Join Darshan Kulkarni as he talks with guest Dr. Stephen Towers about the intersection between marketing and medical affairs. Darshan and Stephen also discuss how medical affairs can inform marketing efforts. The post DarshanTalks: Marketing & Medical Affairs </br>– March 9, 2021 appeared first on Pharma Marketing Network.
Drug Patent Watch
MARCH 19, 2021
Annual Drug Patent Expirations for ARMONAIR+RESPICLICK Armonair Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are eighteen…. The post New patent for Teva Pharm drug ARMONAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
MARCH 18, 2021
An EMA advisory committee’s review of AstraZeneca’s COVID-19 has concluded that there is no increase in the overall risk of blood clots with this vaccine. The chair of the Pharmacovigilance Risk Assessment Committee (PRAC), Dr Sabine Straus, told a press briefing today that the vaccine “is safe and effective and its benefits continue to be far greater than its risks.”.
Pharma Times
MARCH 15, 2021
Phase III trial stopped early for positive result on overall survival
Pharma Mirror
MARCH 17, 2021
Deutsches Zentrum fur Neurodegenerative Erkrankungen and Eisai Co., Ltd. today announced that both parties have entered into a research collaboration agreement aiming to create potential novel treatments for neurodegenerative disorders including Alzheimer’s disease (AD) which modulate immune competence in neurons and glia cells. DZNE is a world-leading interdisciplinary public research organization constituted with ten research sites in Germany that investigates methods for prevention, dia
Drug Patent Watch
MARCH 19, 2021
Annual Drug Patent Expirations for AIRDUO+DIGIHALER Airduo Digihaler is a drug marketed by Teva Pharm and is included in one NDA. It is available from three suppliers. There are twenty-four…. The post New patent for Teva Pharm drug AIRDUO DIGIHALER appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
MARCH 15, 2021
Ireland and the Netherlands have joined Norway, Denmark, Bulgaria and Iceland in suspending vaccinations with Oxford/AstraZeneca’s COVID-19 vaccine, shortly after the World Health Organization came out in support of the shot. . In a statement, Ireland’s chief medical officer Dr Ronan Glynn said that vaccinations would be “temporarily deferred” from the morning of Sunday 14 March “following new information received from the Norwegian Medicines Agency” Glynn says Norway’s regulatory authorit
Pharma Times
MARCH 19, 2021
EP0042 is a dual-inhibitor drug designed to block the activity of two cancer-driving proteins
Pharma Mirror
MARCH 17, 2021
After over a half-century of lobbying, it seems that cannabis prohibition may finally come to an end at the federal level. For a lot of Americans, many of whom have seen their states legalize cannabis and marijuana products to varying degrees, this may seem like a natural course of events for the harmless but controversial plant. Except, cannabis isn’t entirely harmless.
Drug Patent Watch
MARCH 19, 2021
Annual Drug Patent Expirations for AIRDUO+RESPICLICK Airduo Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from three suppliers. There are twenty-one…. The post New patent for Teva Pharm drug AIRDUO RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
MARCH 17, 2021
At the start of the pandemic GlaxoSmithKline made its vaccine booster tech available looking for collaborations with other vaccine developers – but GSK has been lagging behind rivals like Pfizer and AstraZeneca after its big tie-up with Sanofi hit technical troubles. The big UK pharma will be hoping that a partnership with the Canadian biotech Medicago will run more smoothly as a trial of the plant-based vaccine enters its late stage.
Pharma Times
MARCH 16, 2021
Alzheimer’s Drug Discovery Foundation says results are ‘promising’
Drug Channels
MARCH 16, 2021
I am pleased to announce our new 2021 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study: The Latest Trends for U.S. Drug Pricing, Reimbursement, and Patient Costs (press release) We’re offering special discounted pricing if you order before March 28, 2021.
Drug Patent Watch
MARCH 19, 2021
Annual Drug Patent Expirations for XEPI Xepi is a drug marketed by Ferrer Internacional and is included in one NDA. It is available from two suppliers. There are three patents…. The post New patent for Ferrer Internacional drug XEPI appeared first on DrugPatentWatch - Make Better Decisions.
Expert insights. Personalized for you.
145 
Let's personalize your content